Schedule of the Effect of Corrections |
A summary of the effect of the corrections on the condensed consolidated statements of operations for the three and nine months ended October 31, 2021 were as follows (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended October 31, 2021 |
|
Nine Months Ended October 31, 2021 |
|
As reported |
|
Corrections |
|
As Adjusted |
|
As reported |
|
Corrections |
|
As Adjusted |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Research and development |
$ |
16,621 |
|
|
$ |
(30) |
|
|
$ |
16,591 |
|
|
$ |
44,836 |
|
|
$ |
(119) |
|
|
$ |
44,717 |
|
Sales and marketing |
76,191 |
|
|
(1,493) |
|
|
74,698 |
|
|
207,079 |
|
|
(2,506) |
|
|
204,573 |
|
Total operating expenses |
114,645 |
|
|
(1,523) |
|
|
113,122 |
|
|
315,279 |
|
|
(2,625) |
|
|
312,654 |
|
Operating loss |
(26,289) |
|
|
1,523 |
|
|
(24,766) |
|
|
(66,299) |
|
|
2,625 |
|
|
(63,674) |
|
Loss before provision for income taxes |
(27,408) |
|
|
1,523 |
|
|
(25,885) |
|
|
(71,043) |
|
|
2,625 |
|
|
(68,418) |
|
Net loss |
(29,231) |
|
|
1,523 |
|
|
(27,708) |
|
|
(77,175) |
|
|
2,625 |
|
|
(74,550) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to Class A and Class B stockholders, basic and diluted |
$ |
(0.11) |
|
|
$ |
— |
|
|
$ |
(0.11) |
|
|
$ |
(0.44) |
|
|
$ |
0.01 |
|
|
$ |
(0.43) |
|
A summary of the effect of the corrections on the condensed consolidated statements of cash flows for the nine months ended October 31, 2021 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended October 31, 2021 |
|
As reported |
|
Corrections |
|
As Adjusted |
|
|
|
|
|
|
Net loss |
(77,175) |
|
|
2,625 |
|
|
(74,550) |
|
Changes in operating assets and liabilities |
|
|
|
|
|
Prepaid expenses and other current assets |
(1,104) |
|
|
(1,291) |
|
|
(2,395) |
|
Other non-current assets |
(1,817) |
|
|
(1,334) |
|
|
(3,151) |
|
|